Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
- PMID: 33144307
- DOI: 10.1136/annrheumdis-2020-219309
Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'
Keywords: autoimmune diseases; cytokines; glucocorticoids; inflammation; pulmonary fibrosis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Gremese et al.Ann Rheum Dis. 2023 Jan;82(1):e6. doi: 10.1136/annrheumdis-2020-219337. Epub 2020 Nov 3. Ann Rheum Dis. 2023. PMID: 33144306 No abstract available.
Comment on
-
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis.Ann Rheum Dis. 2021 Mar;80(3):384-391. doi: 10.1136/annrheumdis-2020-218946. Epub 2020 Oct 13. Ann Rheum Dis. 2021. PMID: 33051220
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical